Skip To Main Content
Bo Yin on Muck Rack

Bo Yin

As seen in: Nature, Wiley, Wiley Online Library, arXiv, Frontiers, Frontiers in Immunology, MDPI, Taylor & Francis Online, ACS Publications, Science Magazine and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bo

Contact Bo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Standardized chronic disease management reduces comorbidity risk in China

|
By Linfeng Liu, Yanjun Li, Qi Huang, Limei Ke, Guoqing Feng, Bo Yin, Wenxin Xiang, Miao Wang, Yuyang Liu, Qiannan Tian, Liqun Wu, Xiaofeng He, Huatang Zeng, Wannian Liang, Kuiying Gu, Jiming Zhu, Qian Di, Jiayao Zhong
| Nature Verified
Abstract Non-communicable chronic diseases pose a significant public health challenge worldwide. China has launched a nationwide standardized Chronic Disease Patient Management program to provide primary care for patients with hypertension and type 2 diabetes, but its effect on reducing risks of other chronic diseases remains unclear.
Open in Who Shared Issue with article?

A systematic review of brain structural and functional alterations in pediatric mild traumatic brain injury

|
By Hui XU, Siqi Wu, Haocheng Zhan, Guanjinghui Xu, Junjie Zhao, Bo Yin
| Frontiers
Abstract Introduction: Pediatric mild traumatic brain injury (pmTBI) constitutes 70–90% of childhood traumatic brain injury cases. While magnetic resonance imaging (MRI) reveals subtle brain alterations, fragmented evidence across modalities limits understanding of long-term neurobiological consequences.
Open in Who Shared Issue with article?

Identification of LILRB4 as a regulator of M2c macrophages and a potential immunotherapeutic target in ovarian cancer

|
By Huijuan Zhou, Qing Zhang, Bo Yin, Lingfei Han, Xiaohui Huang, ShuangDi Li
| Frontiers in Immunology
Abstract Introduction: Ovarian cancer (OC) is the most lethal gynecological malignancy. A deeper insight into tumor microenvironment (TME) interactions is essential for developing novel therapeutic approaches. leukocyte immunoglobulin-like receptor B4 (LILRB4) is a receptor involved in multiple biological and pathological processes in hematological malignancies; however, its role in the progression of solid tumors remains largely unexplored.
Open in Who Shared Issue with article?
See all 53 licensed articles (55 Total)